Pexastimogene devacirepvec Uses, Dosage, Side Effects and more
Pexastimogene devacirepvec is under investigation in clinical trial NCT00429312 (A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma).
| Attribute | Details |
|---|---|
| Trade Name | Pexastimogene devacirepvec |
| Generic | Pexastimogene devacirepvec |
| Pexastimogene devacirepvec Other Names | Pexastimogene devacirepvec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
